A Brief Note on GLP-2 and GLP-3 While GLP-1 medications are currently the most widely used for weight loss, newer therapies are emerging
- March 5, 2026 - AM-PR In conjunction with Obesity Care Week, a national survey from Phenomix Sciences among medication-experienced patients found that GLP-1 outcomes, tolerability, and downstream care needs vary widely, reinforcing the need for more individualized obesity care
Compounds such as retatrutide , tirzepatide, semaglutide, cagrilintide, and various GIP analogs are increasingly driving innovation throughout the industry
Visual changes : Sudden vision deterioration, floaters, or flashing lights may indicate diabetic retinopathy progression
I lost 50 pounds in just under a year on Ozempic
Muscle tears